Skip to content
Home page - Centenary Institute Centenary Institute

Primary menu

  • Research
        • Research

          The latest medical research into our most complex health challenges across cancer, cardiovascular disease and inflammation

          Learn more

        • Cancer
        • Inflammation
        • Cardiovascular
        • Programs
        • Laboratories
        • Diseases
        • Expertises
        • Services and instrumentation
  • Support us
        • Support us

          By supporting the Centenary Institute you can help improve human health through excellence in medical research

          Learn more

        • Workplace giving
        • Host or join a fundraiser
        • Gift in your Will
        • Donate in Memory
  • Impact
        • Impact

          Our research develops new diagnostics, treatments and cures for some of the most deadly and debilitating diseases affecting society today

          Learn more

        • Breakthroughs
        • Community and research
        • Real stories
  • Health hub
        • Health hub

          A range of practical information to assist in the possible preventions to disease through evidence-based research on how the body works.

          Learn more

        • Inflammation
        • The Good Gut Anti-Inflammatory Diet
        • Ageing
        • Exercise snack program
  • News & events
        • News & Events

          Explore the latest research breakthroughs and ways you can take part in our series of digital and in-person events

        • News
        • Events
        • Media Hub
  • About us
        • About us

          We are world-leading independent medical research institute that drives collaboration to accelerate and translate solutions to our most complex health challenges

          Learn more

        • Governance
        • Corporate information
        • Annual reports
        • Our researchers
        • Careers and studies
        • Contact
  • Donate
    Centenary Institute > News > Discovery could open door to new COPD treatment

Discovery could open door to new COPD treatment

Date time 3 January, 2023
News Type News type Media release
Research led by the Centenary Institute, the University of Technology Sydney and Ghent University Hospital, Belgium has identified a new therapeutic approach for chronic obstructive pulmonary disease (COPD) – the targeting and inhibition of a protein called RIPK1.

The third leading cause of death worldwide and with no effective treatments, COPD is a chronic lung disease also known as emphysema. It is characterised by a mix of airway inflammation and blockage, and lung damage which makes it difficult to breathe.

Reported in the prestigious European Respiratory Journal, the researchers found increased levels of the protein RIPK1 in the lungs of people suffering from COPD as well as in experimental COPD mouse models. Inhibiting RIPK1 helped protect against COPD and may represent a new approach for treatment.

Co-senior study author Professor Phil Hansbro, Director of the Centenary UTS Centre for Inflammation said that the primary risk factor for COPD is smoking tobacco but that the disease can also be caused by breathing in dust, fumes, chemicals and air pollution.

“Cigarette smoke or exposure to other irritants triggers inflammation and can induce cell death in the lungs and airways, which directly contributes to the development of COPD,” Professor Hansbro said.

“We investigated RIPK1 as it plays a key role in cell survival and death as well as inflammation. We found that there were far higher levels of RIPK1 in patients suffering from COPD as well as in our COPD mouse models.”

Subsequent study by the researchers, with COPD mouse models, found that inhibiting RIPK1 provided a significant protective effect against COPD.

“We saw reduced structural changes to the airways and decreased damage to the air sacs of the lungs. Our data indicates that inhibiting RIPK1 lessened both inflammation and the death of healthy lung and airway cells meaning less tissue damage overall,” said Professor Hansbro.

The research team say that their findings provide an exciting new avenue of study for treating COPD, an incurable and often fatal lung disease.

Publication:

RIPK1 kinase-dependent inflammation and cell death contribute to the pathogenesis of COPD. https://erj.ersjournals.com/content/early/2022/12/01/13993003.01506-2022

Themes

  • Inflammation

    Inflammation

Programs

  • Centenary UTS Centre for Inflammation

People

  • Professor Philip Hansbro

    Deputy Director, Centenary Institute. Director, Centenary UTS Centre for Inflammation

Research Fields

  • COPD – Chronic obstructive pulmonary disease

Media enquires

For all media and interview enquiries, please contact Tony Crawshaw, Media and Communications Manager

Phone number Phone Number 0402 770 403

Email Email t.crawshaw@centenary.org.au

Media Release

Discovery could open door to new COPD treatment

Download

Recent Stories

  • Centenary talks healthy ageing at NSW Seniors Expo

    The Centenary Institute has highlighted its critical research into the biology of ageing – aimed at improving the quality of life for older people – at the 2023 NSW Seniors Festival Expo, held at the International Convention Centre, Darling Harbour, Sydney.
    News Type: Community
    Date 07 Feb 2023
  • Centenary Institute announces new Executive Director – a coup to recruit a shining star from Melbourne’s WEHI

    The Centenary Institute is delighted to announce that Professor Marc Pellegrini will join the Centenary Institute as its new Executive Director. A physician, immunologist and internationally renowned research scientist, Professor Pellegrini has over 20 years of experience working on chronic infections.
    News Type: Media release
    Date 30 Jan 2023
  • Centenary researchers ranked among the world’s best

    Seven researchers from the Centenary Institute have been listed among the global top two percent of scientists in their fields – according to a recently published Stanford University study.
    News Type: Research News
    Date 17 Jan 2023
  • Good Gut Anti-Inflammatory Diet book released

    A new book, ‘The Good Gut Anti-Inflammatory Diet’, has been released by the Centenary Institute, which is full of informative knowledge, recipes and advice to maintain good gut health to control inflammation and to help prevent disease.
    News Type: Institute
    Date 10 Jan 2023
    The Good Gut Anti-inflammatory Diet book

Subscribe to receive news on
research updates and free events

Newsletter

The Centenary Institute is a world-leading independent Medical Research Institute.

We acknowledge the Gadigal of the Eora Nation, the traditional custodians of the Country on which the Centenary Institute stands.

About

  • About
  • Governance
  • Corporate information

Research

  • Programs
  • Our researchers
  • News
  • Media hub

Careers & studies

  • Career opportunities
  • Life at Centenary

Links

  • Contact
  • Privacy statement

Contact us

Building 93, Royal Prince Alfred Hospital
Missenden Rd
Camperdown NSW 2050 Australia
Telephone +61 2 9565 6100
Fax +61 2 9565 6101

Centenary Institute ABN 22 654 201 090 (DGR 1) • Centenary Institute Medical Research Foundation ABN 85 778 244 012 (DGR 2)
© 2017 Centenary Institute of Cancer Medicine and Cell Biology.

  • Linkedin
  • Facebook
  • Twitter
  • Youtube
  • Instagram